Evidence map›Paper›PMID 28860761›Full record

ArticleInternational journal of nanomedicine2017

Hyaluronic acid-functionalized bismuth oxide nanoparticles for computed tomography imaging-guided radiotherapy of tumor.

Fengyi Du, Jiaming Lou, Rong Jiang, Zhengzou Fang, Xuefen Zhao, Yuanyuan Niu, Shenqiang Zou, Miaomiao Zhang, Aihua Gong, Chaoyang Wu

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Human serum albumin-based KBiFJournal of nanobiotechnology · 2025
    Article
  6. Review
  7. Article
  8. Biomedical Approach of Nanotechnology and Biological Risks: A Mini-Review.International journal of molecular sciences · 2023
    Review
  9. Bismuth Oxide (BiToxics · 2023
    Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Hybrid FeWOInternational journal of nanomedicine · 2023
    Article
  16. Article
  17. Review
  18. Fabrication of gelatin BiRSC advances · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Fengyi Du *Department of Oncology, The Affiliated People's Hospital, Jiangsu University, Zhenjiang, People's Republic of China.
Jiaming Lou *Department of Oncology, The Affiliated People's Hospital, Jiangsu University, Zhenjiang, People's Republic of China.
Rong Jiang *Department of Cellular Biology, School of Medicine, Jiangsu University, Zhenjiang, People's Republic of China.
Zhengzou Fang *Department of Cellular Biology, School of Medicine, Jiangsu University, Zhenjiang, People's Republic of China.
Xuefen ZhaoDepartment of Cellular Biology, School of Medicine, Jiangsu University, Zhenjiang, People's Republic of China.
Yuanyuan NiuDepartment of Cellular Biology, School of Medicine, Jiangsu University, Zhenjiang, People's Republic of China.
Shenqiang ZouDepartment of Hepatosis, The Third Hospital of Zhenjiang Affiliated, Jiangsu University, Zhenjiang, People's Republic of China.
Miaomiao ZhangDepartment of Cellular Biology, School of Medicine, Jiangsu University, Zhenjiang, People's Republic of China.
Aihua GongDepartment of Cellular Biology, School of Medicine, Jiangsu University, Zhenjiang, People's Republic of China.
Chaoyang WuDepartment of Oncology, The Affiliated People's Hospital, Jiangsu University, Zhenjiang, People's Republic of China.
Jiangsu University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The inherent radioresistance and inaccuracy of localization of tumors weaken the clinical implementation effectiveness of radiotherapy. To overcome these limitations, hyaluronic acid-functionalized bismuth oxide nanoparticles (HA-Bi

Indexed as

AnimalsBismuthCell Line, TumorContrast MediaFemaleHumansHyaluronan ReceptorsHyaluronic AcidMice, Inbred ICRNanoparticlesNeoplasmsRadiation-Sensitizing AgentsRadiotherapy, Image-GuidedTheranostic NanomedicineTissue DistributionTomography, X-Ray ComputedBismuthbismuth oxideCD44 protein, humanContrast MediaHyaluronan ReceptorsHyaluronic AcidRadiation-Sensitizing AgentsbismuthCT imagingHAHA-Bi2O3 NPsradiosensitivity

Identifiers

PMID28860761
PMCPMC5573055
OpenAlexW2749019792

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.